Molecular Diagnostics in Tuberculosis Basis and Implications for Therapy

被引:0
作者
Balasingham, Seetha V.
Davidsen, Tonje
Szpinda, Irena
Frye, Stephan A.
Tonjuin, Tone [1 ]
机构
[1] Oslo Univ Hosp, Rikshosp, Inst Microbiol, Ctr Mol Biol & Neurosci, NO-0027 Oslo, Norway
关键词
POLYMERASE-CHAIN-REACTION; RESISTANT MYCOBACTERIUM-TUBERCULOSIS; ACID AMPLIFICATION TESTS; COBAS AMPLICOR SYSTEM; RIFAMPIN-RESISTANT; RAPID DIAGNOSIS; PULMONARY TUBERCULOSIS; DRUG-RESISTANCE; PCR ASSAY; BRONCHOALVEOLAR LAVAGE;
D O I
10.1007/BF03256322
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The processing of clinical specimens in the mycobacterial diagnostic laboratory has undergone remarkable improvements during the last decade. While microscopy and culture are still the major backbone for laboratory diagnosis of tuberculosis on a worldwide basis, new methods including molecular diagnostic tests have evolved over the last two decades. The majority of molecular tests have been focused on (i) detection of nucleic acids, both DNA and RNA, that are specific to Mycobacterium tuberculosis, by amplification techniques such as polymerase chain reaction (PCR); and (ii) detection of mutations in the genes that are associated with resistance to antituberculosis drugs by sequencing or nucleic acid hybridization. Recent developments in direct and rapid detection of mycobacteria, with emphasis on M. tuberculosis species identification by 16S rRNA gene sequence analysis or oligohybridization and strain typing, as well as detection of drug susceptibility patterns, all contribute to these advances. Generally, the balance between genome instability and genome maintenance as the basis for evolutionary development, strain diversification and resistance development is important, because it cradles the resulting M. tuberculosis phenotype. At the same time, semi-automated culture systems have contributed greatly to the increased sensitivity and reduced turnaround time in the mycobacterial analysis of clinical specimens. Collectively, these advances are particularly important for establishing the diagnosis of tuberculosis in children. More basic and operational research to appraise the impact and cost effectiveness of new diagnostic technologies must, however, be carried out. Furthermore, the design and quality of clinical trials evaluating new diagnostics must be improved to allow clinical and laboratory services that would provide rapid response to test results. Thus, important work remains before the new diagnostic tools can be meaningfully integrated into national tuberculosis control programs of high-burden countries.
引用
收藏
页码:137 / 151
页数:15
相关论文
共 124 条
  • [11] Variations in the Nrampi gene and susceptibility to tuberculosis in West Africans
    Bellamy, R
    Ruwende, C
    Corrah, T
    McAdam, KPWJ
    Whittle, HC
    Hill, AVS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (10) : 640 - 644
  • [12] Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains
    Bifani, PJ
    Mathema, B
    Kurepina, NE
    Kreiswirth, BN
    [J]. TRENDS IN MICROBIOLOGY, 2002, 10 (01) : 45 - 52
  • [13] Peptide nucleic acid probe detection of mutations in Mycobacterium tuberculosis genes associated with drug resistance
    Bockstahler, LE
    Li, Z
    Nguyen, NY
    Van Houten, KA
    Brennan, MJ
    Langone, JJ
    Morris, SL
    [J]. BIOTECHNIQUES, 2002, 32 (03) : 508 - +
  • [14] BODDINGHAUS B, 1990, J CLIN MICROBIOL, V28, P1751
  • [15] Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries
    Boehme, Catharina C.
    Nabeta, Pamela
    Henostroza, German
    Raqib, Rubhana
    Rahim, Zeaur
    Gerhardt, Martina
    Sanga, Erica
    Hoelscher, Michael
    Notomi, Tsugunori
    Hase, Tetsu
    Perkins, Mark D.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (06) : 1936 - 1940
  • [16] Multicenter study of a commercial, automated polymerase chain reaction system for the rapid detection of Mycobacterium tuberculosis in respiratory specimens in routine clinical practice
    Bogard, M
    Vincelette, J
    Antinozzi, R
    Alonso, R
    Fenner, T
    Schirm, J
    Aubert, D
    Gaudreau, C
    Sala, E
    Ruiz-Serrano, MJ
    Petersen, H
    Oostendorp, LAB
    Burkardt, H
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (10) : 724 - 731
  • [17] DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis
    Boshoff, HIM
    Reed, MB
    Barry, CE
    Mizrahi, V
    [J]. CELL, 2003, 113 (02) : 183 - 193
  • [18] Comparison of an internally controlled, large-volume LightCycler assay for detection of Mycobacterium tuberculosis in clinical samples with the COBAS AMPLICOR assay
    Burggraf, S
    Reischl, U
    Malik, N
    Bollwein, M
    Naumann, L
    Olgemöller, B
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (04) : 1564 - 1569
  • [19] Feasibility of shortening respiratory isolation with a single sputum nucleic acid amplification test
    Campos, Michael
    Quartin, Andrew
    Mendes, Eliana
    Abreu, Alexandre
    Gurevich, Samuel
    Echarte, Luis
    Ferreira, Tanira
    Cleary, Timothy
    Hollender, Elena
    Ashkin, David
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 178 (03) : 300 - 305
  • [20] The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis - Results of a multicenter prospective trial
    Catanzaro, A
    Perry, S
    Clarridge, JE
    Dunbar, S
    Goodnight-White, S
    LoBue, PA
    Peter, C
    Pfyffer, GE
    Sierra, MF
    Weber, R
    Woods, G
    Mathews, G
    Jonas, V
    Smith, K
    Della-Latta, P
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (05): : 639 - 645